Editorial: Molecular and cellular pathways underlying neurodegenerative disorders
Frontiers in Cell and Developmental Biology · 31.07.2026 · 14
DOI: 10.3389/fcell.2026.1943531 ↗Kurz gefasst
Editorial in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 31.07.2026. Verfasst von Anastasia Bougea und 2 weiteren Autor:innen. Beteiligte Einrichtung: First Department of Neurology, Medical School National and Kapodistrian University of Athens, Athens, Greece. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- First Department of Neurology, Medical School National and Kapodistrian University of Athens, Athens, Greece.
- NeuroAging Group (NEURAL), Clinical Neurosciences Research Laboratory (LINC), Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain.
- Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.
- Department of Foundations of Medicine, NYU Grossman Long Island School of Medicine, Mineola, NY, United States.
- Department of Medicine, NYU Grossman Long Island School of Medicine, Mineola, NY, United States.
Zitieren
APA
Bougea, A., Ouro, A., & Reiss, A. B. (2026). Editorial: Molecular and cellular pathways underlying neurodegenerative disorders. Frontiers in Cell and Developmental Biology, 14. https://doi.org/10.3389/fcell.2026.1943531
Vancouver
Bougea A, Ouro A, Reiss AB. Editorial: Molecular and cellular pathways underlying neurodegenerative disorders. Frontiers in Cell and Developmental Biology. 2026;14. doi:10.3389/fcell.2026.1943531
BibTeX
@article{Bougea2026,
author = {Bougea, Anastasia and Ouro, Alberto and Reiss, Allison B},
title = {Editorial: Molecular and cellular pathways underlying neurodegenerative disorders},
journal = {Frontiers in Cell and Developmental Biology},
year = {2026},
volume = {14},
doi = {10.3389/fcell.2026.1943531}
}
EUVIMED